Distinct patterns of RANKL/osteoprotegerin system modulation through anti-tumour necrosis factor and corticosteroid therapy in rheumatoid arthritis synovium

Ítems similars

• Anti-tumour necrosis factor therapy modulates the OPG/OPGL system in rheumatoid arthritis synovium
  per: Catrina, AI, et al.
  Publicat: (2004)
• Synovial expression of IL-15 in rheumatoid arthritis is not influenced by blockade of tumour necrosis factor
  per: Ernestam, Sofia, et al.
  Publicat: (2006)
• Therapy with soluble TNF receptor (etanercept) induces apoptosis in rheumatoid arthritis (RA) synovium
  per: Catrina, AI, et al.
  Publicat: (2003)
• Low levels of apoptosis and high FLIP expression in early rheumatoid arthritis synovium
  per: Catrina, A, et al.
  Publicat: (2002)
• Tocilizumab decreases T cells but not macrophages in the synovium of patients with rheumatoid arthritis while it increases the levels of serum interleukin-6 and RANKL
  per: Chatzidionysiou, Katerina, et al.
  Publicat: (2021)